Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2600124631Phase 4Not yet recruiting
Phase 4, randomised trial of ciprofol in gastrointestinal stromal tumor (GIST) (2 arms), sponsored by Anqing Municipal Hospital. Primary endpoint: Incidence of postoperative delirium within three days after surgery. Planned start May 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2600124631.